keyword
https://read.qxmd.com/read/38636110/a-systematic-review-of-the-mozart-effect-in-adult-and-paediatric-cases-of-drug-resistant-epilepsy-a-sound-approach-to-epilepsy-management
#1
REVIEW
Lucrezia Maria Piccicacchi, Domenico Serino
OBJECTIVES: In recent years, adjunctive therapies for epilepsy management are being explored due to considerable side effects carried by antiepileptic drugs (AEDs) and widespread reports of drug-resistant epilepsy. One such approach is non-invasive musical neurostimulation. Within this context, Mozart's sonata K448 has received particular attention following reports of reduced seizure frequency and a decrease in epileptiform discharges during and after music exposure; often described as the 'Mozart effect'...
April 17, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38636107/comparative-analysis-of-adverse-drug-reactions-associated-with-new-antiseizure-medications-from-the-korea-adverse-event-reporting-system-database
#2
JOURNAL ARTICLE
Hyun Kyung Kim, Kyung Sik Jang, Dong Wook Kim
OBJECTIVE: This study aimed to compare and characterize the safety profiles of new antiseizure medications (ASMs) using a nationwide pharmacovigilance database from a long-term perspective in Korea. METHODS: We reviewed adverse event reports from the Korea Adverse Event Reporting System database between January 2013 and December 2022 for descriptive analysis of six new ASMs (lacosamide, levetiracetam, lamotrigine, oxcarbazepine, topiramate, and zonisamide). We investigated the frequency and characteristics of adverse drug reactions (ADRs) based on the MedDRA terminology, system organ classes, and modified WHO classification...
April 16, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38636099/ldl-c-and-tc-mediate-the-risk-of-pnpla3-inhibition-on-cardiovascular-diseases
#3
JOURNAL ARTICLE
Genshan Zhang, Wei Jiang, Fangxun He, Jie Fu, Xiangshang Xu, Xuelai Luo, Zhixin Cao
BACKGROUND: PNPLA3 is a promising target for the treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. ARO-PNPLA3 is a drug that efficiently lowers PNPLA3 expression in hepatocytes at the mRNA level, resulting in a significant reduction in liver fat in Phase I clinical trials. However, the long-term effects and potential side effects of ARO-PNPLA3 are not well understood. METHODS: We conducted a two-sample, two-step Mendelian randomization (MR) analysis to investigate the association between PNPLA3 inhibition and 10 cardiovascular diseases (CVDs), as well as the role of lipid traits as mediators...
April 18, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38636082/comparison-of-opioid-use-disorder-patients-with-and-without-problematic-internet-use-in-terms-of-impulsivity-and-attention-deficit-hyperactivity-disorder
#4
JOURNAL ARTICLE
Neşe Burcu Bal, Bahar Yeşil Örnek
AIMS: This study seeks to investigate ADHD symptoms and impulsivity among individuals diagnosed with Opioid Use Disorder (OUD) who also exhibit symptoms of Problematic Internet Use (PIU). METHODS: The study involved the participation of 360 Opioid Use Disorder (OUD) patients enrolled at an Alcohol and Drug Addiction Treatment Center (ADATC) during the period from October to December 2022. Various assessment tools were administered, including Young's Internet Addiction Scale (YIAS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Barratt Impulsiveness Scale (BIS), and Adult ADHD Self-Report Scale (ASRS)...
April 18, 2024: Revista Brasileira de Psiquiatria
https://read.qxmd.com/read/38635981/the-alzheimer-s-knowledge-base-a-knowledge-graph-for-alzheimer-disease-research
#5
JOURNAL ARTICLE
Joseph D Romano, Van Truong, Rachit Kumar, Mythreye Venkatesan, Britney E Graham, Yun Hao, Nick Matsumoto, Xi Li, Zhiping Wang, Marylyn D Ritchie, Li Shen, Jason H Moore
BACKGROUND: As global populations age and become susceptible to neurodegenerative illnesses, new therapies for Alzheimer disease (AD) are urgently needed. Existing data resources for drug discovery and repurposing fail to capture relationships central to the disease's etiology and response to drugs. OBJECTIVE: We designed the Alzheimer's Knowledge Base (AlzKB) to alleviate this need by providing a comprehensive knowledge representation of AD etiology and candidate therapeutics...
April 18, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38635979/self-reported-disability-type-and-risk-of-alcohol-induced-death-a-longitudinal-study-using-nationally-representative-data
#6
JOURNAL ARTICLE
Jonathan Aram, Natalie Slopen, Candace Cosgrove, Amelia Arria, Hongjie Liu, Cher M Dallal
BACKGROUND: Disability is associated with alcohol misuse and drug overdose death, however, its association with alcohol-induced death remains understudied. OBJECTIVE: To quantify the risk of alcohol-induced death among adults with different types of disabilities in a nationally representative longitudinal sample of US adults. METHODS: Persons with disabilities were identified among participants ages 18 or older in the Mortality Disparities in American Communities (MDAC) study ( n  = 3,324,000)...
April 18, 2024: Substance Use & Misuse
https://read.qxmd.com/read/38635936/methodology-for-using-real-world-data-from-electronic-health-records-to-assess-chemotherapy-administration-in-women-with-breast-cancer
#7
JOURNAL ARTICLE
Jenna Bhimani, Kelli O'Connell, Isaac J Ergas, Marilyn Foley, Grace B Gallagher, Jennifer J Griggs, Narre Heon, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce H Kroenke, Cecile A Laurent, Raymond Liu, Kanichi G Nakata, Sonia Persaud, Donna R Rivera, Janise M Roh, Sara Tabatabai, Emily Valice, Erin J A Bowles, Elisa V Bandera, Lawrence H Kushi, Elizabeth D Kantor
PURPOSE: Identification of patients' intended chemotherapy regimens is critical to most research questions conducted in the real-world setting of cancer care. Yet, these data are not routinely available in electronic health records (EHRs) at the specificity required to address these questions. We developed a methodology to identify patients' intended regimens from EHR data in the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study. METHODS: In women older than 18 years, diagnosed with primary stage I-IIIA breast cancer at Kaiser Permanente Northern California (2006-2019), we categorized participants into 24 drug combinations described in National Comprehensive Cancer Network guidelines for breast cancer treatment...
April 2024: JCO Clinical Cancer Informatics
https://read.qxmd.com/read/38635935/tumor-size-is-not-everything-advancing-radiomics-as-a-precision-medicine-biomarker-in-oncology-drug-development-and-clinical-care-a-report-of-a-multidisciplinary-workshop-coordinated-by-the-recist-working-group
#8
JOURNAL ARTICLE
Erica C Nakajima, Amber Simpson, Jan Bogaerts, Elisabeth G E de Vries, Richard Do, Elena Garalda, Greg Goldmacher, Paul E Kinahan, Philippe Lambin, Barbara LeStage, Qin Li, Frank Lin, Saskia Litière, Raquel Perez-Lopez, Nicholas Petrick, Lawrence Schwartz, Lesley Seymour, Lalitha Shankar, Scott A Laurie
Radiomics, the science of extracting quantifiable data from routine medical images, is a powerful tool that has many potential applications in oncology. The Response Evaluation Criteria in Solid Tumors Working Group (RWG) held a workshop in May 2022, which brought together various stakeholders to discuss the potential role of radiomics in oncology drug development and clinical trials, particularly with respect to response assessment. This article summarizes the results of that workshop, reviewing radiomics for the practicing oncologist and highlighting the work that needs to be done to move forward the incorporation of radiomics into clinical trials...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38635910/nanomedomics
#9
REVIEW
Ganghao Liang, Wanqing Cao, Dongsheng Tang, Hanchen Zhang, Yingjie Yu, Jianxun Ding, Johannes Karges, Haihua Xiao
Nanomaterials have attractive physicochemical properties. A variety of nanomaterials such as inorganic, lipid, polymers, and protein nanoparticles have been widely developed for nanomedicine via chemical conjugation or physical encapsulation of bioactive molecules. Superior to traditional drugs, nanomedicines offer high biocompatibility, good water solubility, long blood circulation times, and tumor-targeting properties. Capitalizing on this, several nanoformulations have already been clinically approved and many others are currently being studied in clinical trials...
April 18, 2024: ACS Nano
https://read.qxmd.com/read/38635904/pharmacometric-in-silico-studies-used-to-facilitate-a-national-dose-standardisation-process-in-neonatology-application-to-amikacin
#10
JOURNAL ARTICLE
Verena Gotta, Julia Anna Bielicki, Paolo Paioni, Chantal Csajka, Dominic Stefan Bräm, Christoph Berger, Elisabeth Giger, Michael Buettcher, Klara M Posfay-Barbe, John Van den Anker, Marc Pfister
BACKGROUND AND AIMS: Pharmacometric in silico approaches are frequently applied to guide decisions concerning dosage regimes during the development of new medicines. We aimed to demonstrate how such pharmacometric modelling and simulation can provide a scientific rationale for optimising drug doses in the context of the Swiss national dose standardisation project in paediatrics using amikacin as a case study. METHODS: Amikacin neonatal dosage is stratified by post-menstrual age (PMA) and post-natal age (PNA) in Switzerland and many other countries...
April 8, 2024: Swiss Medical Weekly
https://read.qxmd.com/read/38635889/pregabalin-induced-delayed-cutaneous-hypersensitivity-reaction-occurring-after-40-days-of-use-a-case-report
#11
JOURNAL ARTICLE
Mi Zhang, Kairong Du, Yun Lu, Wei Wu, Huan Yan, Qiaoli Jiang, Liang Liu, Xiaobo Feng
Pregabalin is the first-line treatment for neuropathic pain. Cases of cutaneous hypersensitivity reactions caused by pregabalin generally occur within 2 weeks of initiating medication. We report a rare case of a delayed cutaneous hypersensitivity reaction caused by pregabalin, which was confirmed by a drug provocation test. A 72-year-old man with severe herpes zoster neuralgia developed maculopapular drug eruption covering 80% to 90% of his total body surface area after 40 days of combined multidrug analgesia...
April 2024: Journal of International Medical Research
https://read.qxmd.com/read/38635880/a-strain-promoted-divergent-chemical-steroidation-unveils-potent-anti-inflammatory-pseudo-steroidal-glycosides
#12
JOURNAL ARTICLE
Han Ding, Xiao-Lin Zhang, Aoxin Guo, Qian Ping Lee, Chao Cai, Ming Li, Hongzhi Cao, Xue-Wei Liu
The development of novel agents with immunoregulatory effects is a keen way to combat the growing threat of inflammatory storms to global health. To synthesize pseudo-steroidal glycosides tethered by ether bonds with promising immunomodulatory potential, we develop herein a highly effective deoxygenative functionalization of a novel steroidal donor (steroidation) facilitated by strain-release, leveraging cost-effective and readily available Sc(OTf)3 catalysis. This transformation produces a transient steroid-3-yl carbocation which readily reacts with O -, C -, N -, S -, and P -nucleophiles to generate structurally diverse steroid derivatives...
April 18, 2024: Journal of the American Chemical Society
https://read.qxmd.com/read/38635879/selective-elimination-of-senescent-cancer-cells-by-galacto-modified-protacs
#13
JOURNAL ARTICLE
Mengyang Chang, Feng Gao, Giri Gnawali, Hang Xu, Yue Dong, Xiang Meng, Wenpan Li, Zhiren Wang, Byrdie Lopez, Jennifer S Carew, Steffan T Nawrocki, Jianqin Lu, Qing-Yu Zhang, Wei Wang
Although the selective and effective clearance of senescent cancer cells can improve cancer treatment, their development is confronted by many challenges. As part of efforts designed to overcome these problems, prodrugs, whose design is based on senescence-associated β-galactosidase (SA-β-gal), have been developed to selectively eliminate senescent cells. However, chemotherapies relying on targeted molecular inhibitors as senolytic drugs can induce drug resistance. In the current investigation, we devised a new strategy for selective degradation of target proteins in senescent cancer cells that utilizes a prodrug composed of the SA-β-gal substrate galactose (galacto) and the proteolysis-targeting chimeras (PROTACs) as senolytic agents...
April 18, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38635863/a-700%C3%A2-nm-led-light-activated-ru-ii-complex-destroys-tumor-cytoskeleton-via-photosensitization-and-photocatalysis
#14
JOURNAL ARTICLE
Anyi Dao, Shiyan Chen, Li Pan, Qingyan Ren, Xun Wang, Haorui Wu, Qiufang Gong, Zeduan Chen, Shaomin Ji, Jiaxi Ru, HaoTu Zhu, Chao Liang, Pingyu Zhang, Haiping Xia, Huaiyi Huang
Photoactivable chemotherapy (PACT) using metallic complexes provides spatiotemporal selectivity over drug activation for targeted anticancer therapy. However, the poor absorption in near-infrared (NIR) light region of most metallic complexes renders tissue penetration challenging. Herein, we present an NIR light triggered di-nuclear photoactivable Ru(II) complex (Ru2) and comprehensively investigated the antitumor mechanism. The introduction of a donor-acceptor-donor (D-A-D) linker greatly enhances the intramolecular charge transition, resulting in a high molar extinction coefficient in the NIR region with an extended triplet excited state lifetime...
April 18, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38635857/dissolving-hyaluronic-acid-based-microneedles-to-transdermally-deliver-eugenol-combined-with-photothermal-therapy-for-acne-vulgaris-treatment
#15
JOURNAL ARTICLE
Qi Wang, Zhiyang Gan, Xinxin Wang, Xinying Li, Lei Zhao, Derong Li, Zhilang Xu, Changdao Mu, Liming Ge, Defu Li
A microneedle transdermal drug delivery system simultaneously avoids systemic toxicity of oral administration and low efficiency of traditional transdermal administration, which is of great significance for acne vulgaris therapy. Herein, eugenol-loaded hyaluronic acid-based dissolving microneedles (E@P-EO-HA MNs) with antibacterial and anti-inflammatory activities are developed for acne vulgaris therapy via eugenol transdermal delivery integrated with photothermal therapy. E@P-EO-HA MNs are pyramid-shaped with a sharp tip and a hollow cavity structure, which possess sufficient mechanical strength to penetrate the stratum corneum of the skin and achieve transdermal delivery, in addition to excellent in vivo biocompatibility...
April 18, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38635841/adaptation-of-the-mycobacterium-tuberculosis-transcriptome-to-biofilm-growth
#16
JOURNAL ARTICLE
Madison A Youngblom, Tracy M Smith, Holly J Murray, Caitlin S Pepperell
Mycobacterium tuberculosis (M. tb), the causative agent of tuberculosis (TB), is a leading global cause of death from infectious disease. Biofilms are increasingly recognized as a relevant growth form during M. tb infection and may impede treatment by enabling bacterial drug and immune tolerance. M. tb has a complicated regulatory network that has been well-characterized for many relevant disease states, including dormancy and hypoxia. However, despite its importance, our knowledge of the genes and pathways involved in biofilm formation is limited...
April 18, 2024: PLoS Pathogens
https://read.qxmd.com/read/38635840/impact-of-conflict-on-the-elimination-targets-of-lymphatic-filariasis-schistosomiasis-and-soil-transmitted-helminths-in-cabo-delgado-province-mozambique
#17
JOURNAL ARTICLE
Xavier Badia-Rius, Henis Mior Sitoe, Sergio Lopes, Louise A Kelly-Hope
BACKGROUND: Mozambique has one of the highest burdens of neglected tropical diseases in Africa. Lymphatic filariasis, schistosomiasis and soil-transmitted helminths are being targeted for elimination as part of integrated mass drug administration campaigns. The progress made towards interruption of transmission has been affected by recent conflict in Cabo Delgado province. The aim of this paper was to determine the potential impact of this crisis on the neglected tropical diseases programme and the challenges in reaching the elimination goals of 2030...
April 18, 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38635836/ranking-of-cell-clusters-in-a-single-cell-rna-sequencing-analysis-framework-using-prior-knowledge
#18
JOURNAL ARTICLE
Anastasis Oulas, Kyriaki Savva, Nestoras Karathanasis, George M Spyrou
Prioritization or ranking of different cell types in a Single-cell RNA Sequencing (scRNA-Seq) framework can be performed in a variety of ways, some of these include: i) obtaining an indication of the proportion of cell types between the different conditions under study, ii) counting the number of differentially expressed genes (DEGs) between cell types and conditions in the experiment or, iii) prioritizing cell types based on prior knowledge about the conditions under study (i.e., a specific disease). These methods have drawbacks and limitations thus novel methods for improving cell ranking are required...
April 18, 2024: PLoS Computational Biology
https://read.qxmd.com/read/38635830/-in-vitro-enzymatic-in-silico-adme-and-molecular-docking-based-analysis-for-the-identification-of-novel-bis-indole-containing-triazine-thiazole-hybrids-derivatives-as-promising-urease-inhibitors
#19
JOURNAL ARTICLE
Shoaib Khan, Rafaqat Hussain, Yousaf Khan, Tayyiaba Iqbal, Saeed Anwar, Tariq Aziz, Metab Alharbi
The current study details a sequence of sequential reactions for synthesizing bis-indole-based triazine bearing thiazole derivatives. Several steps were involved in the synthesis of bis-indole-based triazine bearing thiazole derivative. The synthetic reactions were monitored via thin-layer chromatography (TLC). Synthesized compounds were characterized using various spectroscopic techniques, including 1 H NMR, 13 C NMR, and HR-EIMS. The inhibitory activity against urease enzyme of these synthesized compounds was compared with that of thiourea, a standard drug (IC50  = 9...
April 19, 2024: Zeitschrift Für Naturforschung. C, A Journal of Biosciences
https://read.qxmd.com/read/38635829/geraniol-and-citral-recent-developments-in-their-anticancer-credentials-opening-new-vistas-in-complementary-cancer-therapy
#20
REVIEW
Gauri Srivastava, Esha Mukherjee, Ruchika Mittal, Deepak Ganjewala
About 10 million people are diagnosed with cancer each year. Globally, it is the second leading cause of death after heart disease, and by 2035, the death toll could reach 14.6 million. Several drugs and treatments are available to treat cancer, but survival rates remain low. Many studies in recent years have shown that plant-derived monoterpenes, particularly geraniol and citral, are effective against various cancers, including breast, liver, melanoma, endometrial, colon, prostate, and skin cancers. This trend has opened new possibilities for the development of new therapeutics or adjuvants in the field of cancer therapy...
April 19, 2024: Zeitschrift Für Naturforschung. C, A Journal of Biosciences
keyword
keyword
2429
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.